1yok
From Proteopedia
(Difference between revisions)
(9 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | {{Seed}} | ||
- | [[Image:1yok.png|left|200px]] | ||
- | + | ==crystal structure of human LRH-1 bound with TIF-2 peptide and phosphatidylglycerol== | |
- | + | <StructureSection load='1yok' size='340' side='right'caption='[[1yok]], [[Resolution|resolution]] 2.50Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[1yok]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1YOK OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1YOK FirstGlance]. <br> | |
- | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.5Å</td></tr> | |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=P6L:(2S)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(6E)-HEXADEC-6-ENOYLOXY]PROPYL+(8E)-OCTADEC-8-ENOATE'>P6L</scene></td></tr> | |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1yok FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1yok OCA], [https://pdbe.org/1yok PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1yok RCSB], [https://www.ebi.ac.uk/pdbsum/1yok PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1yok ProSAT]</span></td></tr> | |
+ | </table> | ||
+ | == Disease == | ||
+ | [https://www.uniprot.org/uniprot/NCOA2_HUMAN NCOA2_HUMAN] Note=Chromosomal aberrations involving NCOA2 may be a cause of acute myeloid leukemias. Inversion inv(8)(p11;q13) generates the KAT6A-NCOA2 oncogene, which consists of the N-terminal part of KAT6A and the C-terminal part of NCOA2/TIF2. KAT6A-NCOA2 binds to CREBBP and disrupts its function in transcription activation. | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/NCOA2_HUMAN NCOA2_HUMAN] Transcriptional coactivator for steroid receptors and nuclear receptors. Coactivator of the steroid binding domain (AF-2) but not of the modulating N-terminal domain (AF-1). Required with NCOA1 to control energy balance between white and brown adipose tissues.<ref>PMID:9430642</ref> | ||
+ | == Evolutionary Conservation == | ||
+ | [[Image:Consurf_key_small.gif|200px|right]] | ||
+ | Check<jmol> | ||
+ | <jmolCheckbox> | ||
+ | <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/yo/1yok_consurf.spt"</scriptWhenChecked> | ||
+ | <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked> | ||
+ | <text>to colour the structure by Evolutionary Conservation</text> | ||
+ | </jmolCheckbox> | ||
+ | </jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=1yok ConSurf]. | ||
+ | <div style="clear:both"></div> | ||
- | == | + | ==See Also== |
- | + | *[[Liver receptor homolog-1|Liver receptor homolog-1]] | |
- | + | == References == | |
- | + | <references/> | |
- | + | __TOC__ | |
- | + | </StructureSection> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | == | + | |
- | < | + | |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
- | [[Category: Bynum | + | [[Category: Large Structures]] |
- | [[Category: Fletterick | + | [[Category: Bynum JM]] |
- | [[Category: Guy | + | [[Category: Fletterick RJ]] |
- | [[Category: Ingraham | + | [[Category: Guy RK]] |
- | [[Category: Juzumiene | + | [[Category: Ingraham HA]] |
- | [[Category: Krylova | + | [[Category: Juzumiene D]] |
- | [[Category: Lebedeva | + | [[Category: Krylova IN]] |
- | [[Category: MacKay | + | [[Category: Lebedeva L]] |
- | [[Category: Madauss | + | [[Category: MacKay JA]] |
- | [[Category: Montana | + | [[Category: Madauss K]] |
- | [[Category: Moore | + | [[Category: Montana V]] |
- | [[Category: Sablin | + | [[Category: Moore J]] |
- | [[Category: Suzawa | + | [[Category: Sablin EP]] |
- | [[Category: Thornton | + | [[Category: Suzawa M]] |
- | [[Category: Waitt | + | [[Category: Thornton JW]] |
- | [[Category: Williams | + | [[Category: Waitt GM]] |
- | [[Category: Williams | + | [[Category: Williams JD]] |
- | [[Category: Willson | + | [[Category: Williams SP]] |
- | [[Category: Xu | + | [[Category: Willson TM]] |
- | + | [[Category: Xu RX]] | |
- | + | ||
- | + | ||
- | + | ||
- | + |
Current revision
crystal structure of human LRH-1 bound with TIF-2 peptide and phosphatidylglycerol
|
Categories: Homo sapiens | Large Structures | Bynum JM | Fletterick RJ | Guy RK | Ingraham HA | Juzumiene D | Krylova IN | Lebedeva L | MacKay JA | Madauss K | Montana V | Moore J | Sablin EP | Suzawa M | Thornton JW | Waitt GM | Williams JD | Williams SP | Willson TM | Xu RX